نتایج جستجو برای: mers

تعداد نتایج: 3275  

Journal: :Journal of virology 2015
Yang Yang Chang Liu Lanying Du Shibo Jiang Zhengli Shi Ralph S Baric Fang Li

To understand how Middle East respiratory syndrome coronavirus (MERS-CoV) transmitted from bats to humans, we compared the virus surface spikes of MERS-CoV and a related bat coronavirus, HKU4. Although HKU4 spike cannot mediate viral entry into human cells, two mutations enabled it to do so by allowing it to be activated by human proteases. These mutations are present in MERS-CoV spike, explain...

2015
Ziad A Memish Ahmad Alsahly Malak al Masri Gary L Heil Benjamin D Anderson Malik Peiris Salah Uddin Khan Gregory C Gray

Middle East respiratory syndrome coronavirus (MERS-CoV) is an emerging viral pathogen that primarily causes respiratory illness. We conducted a seroprevalence study of banked human serum samples collected in 2012 from Southern Saudi Arabia. Sera from 300 animal workers (17% with daily camel exposure) and 50 non-animal-exposed controls were examined for serological evidence of MERS-CoV infection...

2013
Zhaohui Qian Samuel R. Dominguez Kathryn V. Holmes

Little is known about the biology of the emerging human group c betacoronavirus, Middle East Respiratory Syndrome coronavirus (MERS-CoV). Because coronavirus spike glycoproteins (S) mediate virus entry, affect viral host range, and elicit neutralizing antibodies, analyzing the functions of MERS-CoV S protein is a high research priority. MERS-CoV S on lentivirus pseudovirions mediated entry into...

2017
Mostafa A. Abolfotouh Ali A. AlQarni Suliman M. Al-Ghamdi Mahmoud Salam Mohammed H. Al-Assiri Hanan H. Balkhy

BACKGROUND Middle East Respiratory Syndrome (MERS) is caused by MERS coronavirus (MERS-CoV). More than 80% of reported cases have occurred in Saudi Arabia, with a mortality exceeding 50%. Health-care workers (HCWs) are at risk of acquiring and transmitting this virus, so the concerns of HCWs in Saudi Arabia regarding MERS were evaluated. METHODS An anonymous, self-administered, previously val...

Journal: :Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin 2013
M G Hemida R A Perera P Wang M A Alhammadi L Y Siu M Li L L Poon L Saif A Alnaeem M Peiris

In Saudi Arabia, including regions of Riyadh and Al Ahsa, pseudoparticle neutralisation (ppNT) and microneutralisation (MNT) tests detected no antibodies to Middle East Respiratory Syndrome coronavirus (MERS-CoV) in sheep (n= 100), goats (n= 45), cattle (n= 50) and chickens (n= 240). Dromedary camels however, had a high prevalence of MERS-CoV antibodies. Bovine coronavirus (BCoV) infected sera ...

Journal: :Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2016
Myoung-Don Oh

BACKGROUND Although Middle East Respiratory Syndrome coronavirus (MERS-CoV) is characterized by a risk of nosocomial transmission, the detailed mode of transmission and period of virus shedding from infected patients are poorly understood. The aims of this study were to investigate the potential role of environmental contamination by MERS-CoV in healthcare settings and to define the period of v...

2014
Thomas Briese Nischay Mishra Komal Jain Iyad S. Zalmout Omar J. Jabado William B. Karesh Peter Daszak Osama B. Mohammed Abdulaziz N. Alagaili W. Ian Lipkin

ABSTRACT Complete Middle East respiratory syndrome coronavirus (MERS-CoV) genome sequences were obtained from nasal swabs of dromedary camels sampled in the Kingdom of Saudi Arabia through direct analysis of nucleic acid extracts or following virus isolation in cell culture. Consensus dromedary MERS-CoV genome sequences were the same with either template source and identical to published human ...

2015
Yaseen Arabi Hanan Balkhy Ali H. Hajeer Abderrezak Bouchama Frederick G. Hayden Awad Al-Omari Fahad M. Al-Hameed Yusri Taha Nahoko Shindo John Whitehead Laura Merson Sameera AlJohani Khalid Al-Khairy Gail Carson Thomas C. Luke Lisa Hensley Abdulaziz Al-Dawood Saad Al-Qahtani Kayvon Modjarrad Musharaf Sadat Gernot Rohde Catherine Leport Robert Fowler

As of September 30, 2015, a total of 1589 laboratory-confirmed cases of infection with the Middle East respiratory syndrome coronavirus (MERS-CoV) have been reported to the World Health Organization (WHO). At present there is no effective specific therapy against MERS-CoV. The use of convalescent plasma (CP) has been suggested as a potential therapy based on existing evidence from other viral i...

Journal: :Journal of virology 2015
Bart L Haagmans Judith M A van den Brand Lisette B Provacia V Stalin Raj Koert J Stittelaar Sarah Getu Leon de Waal Theo M Bestebroer Geert van Amerongen Georges M G M Verjans Ron A M Fouchier Saskia L Smits Thijs Kuiken Albert D M E Osterhaus

The ability of Middle East respiratory syndrome coronavirus (MERS-CoV) to infect small animal species may be restricted given the fact that mice, ferrets, and hamsters were shown to resist MERS-CoV infection. We inoculated rabbits with MERS-CoV. Although virus was detected in the lungs, neither significant histopathological changes nor clinical symptoms were observed. Infectious virus, however,...

Journal: :Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin 2013
C B Reusken M Ababneh V S Raj B Meyer A Eljarah S Abutarbush G J Godeke T M Bestebroer I Zutt M A Muller B J Bosch P J Rottier A D Osterhaus C Drosten B L Haagmans M P Koopmans

Between June and September 2013, sera from 11 dromedary camels, 150 goats, 126 sheep and 91 cows were collected in Jordan, where the first human Middle-East respiratory syndrome (MERS) cluster appeared in 2012. All sera were tested for MERS-coronavirus (MERS-CoV) specific antibodies by protein microarray with confirmation by virus neutralisation. Neutralising antibodies were found in all camel ...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید